$AQMS Cashflow Statement | Understand Stock

$AQMS

$1.50 +$0.03 (2.04%) Close

$AQMS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Reconciliation of net loss to net cash used in operating activities
Depreciation and ROU asset amortization
Amortization of intellectual property
Accretion of asset retirement obligation
Warrant expense
Fair value of common stock issued for consulting services
Fair value of common stock issued for director fees
Stock-based compensation
Change in fair value of warrant liability
Amortization of deferred financing costs
Loss (gain) on disposal of property, plant and equipment
Forgiveness of PPP loan
Impairment of equipment deposits
Asset under Construction
Total impairment of equipment deposits
Retirement of asset retirement obligation
Lease of building
Impairment of LINICO investment
Loss on extinguishment of debt
Impairment and loss on disposal of property, plant and equipment
Inventory NRV adjustment
Write off of debt issuance costs
Accrued interest expense

Changes in operating assets and liabilities
Proceeds from sale and leasing of building
Accounts receivable
Inventory
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Other assets and liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property, plant and equipment
Proceeds from sale of equipment
Equipment deposits and other assets
Insurance proceeds
Investment in LINICO
Proceeds from note receivable - LINICO
Proceeds from refund of equipment deposit
Payments for note receivable - LION ENERGY
Equipment deposits
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from PPP loan
Proceeds from issuance of common stock, net of transaction costs
Proceeds from issuance of common stock for exercise of pre-funded warrants
Proceeds from employee stock purchase plan
Payments on note payable
Principal payments on finance leases
Proceeds from note payable
Related Party
Nonrelated Party
Total proceeds from note payable
Proceeds from exercise of stock options
Cash paid for tax withholdings on RSUs vesting
Cash paid for reverse split fractional shares
Debt issuance costs
Proceeds from ELOC, net
ELOC
ATM
Total proceeds from ELOC, net
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash transactions
Fair value of common stock issued to consultants
Acquisitions of property, plant and equipment included in accounts payable
Acquisitions of property, plant and equipment included in accrued expenses
Change in equity resulting from change in accrued expenses
Increase in note receivable resulting from sale of investment
Increase in equity included in accrued expenses
Change in other assets to extinguish notes payable
Change in insurance proceeds receivable resulting from insurance funds held in escrow
Acquisitions of property, plant and equipment paid by prior-period deposits

Comments